AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ISLAND PHARMACEUTICALS LTD

0.455

-0.015-3.19%

Volume:230.45K

Turnover:106.20K

Market Cap:122.42M

PE:-20.12

High:0.470

Open:0.460

Low:0.455

Close:0.470

52wk High:0.630

52wk Low:0.120

Shares:269.05M

Float Shares:110.76M

Volume Ratio:0.69

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.023

EPS(LYR):-0.023

ROE:-90.37%

ROA:-49.16%

PB:17.11

PE(LYR):-20.12

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Island Pharmaceuticals Secures US Patent for Antiviral Drug; Shares Rise 7%

MT Newswires Live

Island Pharmaceuticals Secures Over AU$1 Million in New Funding

MT Newswires Live

Island Pharmaceuticals Secures Membership to Medical Countermeasures Coalition, Shares Reach All-Time Peak

MT Newswires Live

Island Pharmaceuticals Says FDA Confirms Animal Rule Pathway Appropriate for Approval of Marburg Virus Countermeasures, Shares Reach All-Time Peak

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ILA.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ILA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","market":"AU","secType":"STK","nameCN":"ISLAND PHARMACEUTICALS LTD","latestPrice":0.455,"timestamp":1765516320000,"preClose":0.47,"halted":0,"volume":230447,"delay":0,"nameEN":"ISLAND PHARMACEUTICALS LTD","floatShares":110756995,"shares":269052397,"eps":-0.022614,"marketStatus":"Market Closed","change":-0.015,"latestTime":"12-12 16:12:00 AEDT","open":0.46,"high":0.47,"low":0.455,"amount":106200,"amplitude":0.031915,"askPrice":0.46,"askSize":2774,"bidPrice":0.45,"bidSize":73406,"shortable":3,"etf":0,"ttmEps":-0.022614,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1765753200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.47,"openAndCloseTimeList":[[1765494000000,1765515600000]],"volumeRatio":0.6886061321335166,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","floatShares":110756995,"roa":"-49.16%","roe":"-90.37%","lyrEps":-0.022614,"volumeRatio":0.6886061321335166,"shares":269052397,"dividePrice":0,"high":0.47,"amplitude":0.031915,"preClose":0.47,"low":0.455,"week52Low":0.12,"pbRate":"17.11","psRate":"1029.51","week52High":0.63,"institutionHeld":0,"latestPrice":0.455,"committee":0.927172,"eps":-0.022614,"divideRate":0,"volume":230447,"delay":0,"ttmEps":-0.022614,"open":0.46,"prevYearClose":0.17,"prevWeekClose":0.53,"prevMonthClose":0.525,"prevQuarterClose":0.44,"fiveDayClose":0.53,"twentyDayClose":0.425,"sixtyDayClose":0.435,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ILA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ILA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ILA.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589273853","title":"Island Pharmaceuticals Secures US Patent for Antiviral Drug; Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589273853","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589273853?lang=en_us&edition=fundamental","pubTime":"2025-12-05 07:27","pubTimestamp":1764890854,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  received a patent from the US Patent and Trademark Office for the use of its antiviral drug, Galidesivir, in the treatment of COVID-19, according to a Friday filing with the Australian bourse.The US patent provides the company with protection to pursue treatment options for COVID-19 infections using Galidesivir until July 18, 2042, the filing said.Shares of the company rose 7% in recent Friday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","BK7096"],"gpt_icon":0},{"id":"2588096797","title":"Island Pharmaceuticals Secures Over AU$1 Million in New Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2588096797","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588096797?lang=en_us&edition=fundamental","pubTime":"2025-12-03 11:00","pubTimestamp":1764730846,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  has secured over AU$1 million through the exercise of 14.4 million options at AU$0.07 each by existing and substantial shareholders, according to a Wednesday Australian bourse filing.The funds will be used to drive regulatory initiatives under the US Food and Drug Administration animal rule pathway and support US government engagement to position Galidesivir for inclusion in national stockpiles as a key antiviral countermeasure, the filing added.The company's shares fell 2% in recent Wednesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"gpt_icon":0},{"id":"2585860434","title":"Island Pharmaceuticals Secures Membership to Medical Countermeasures Coalition, Shares Reach All-Time Peak","url":"https://stock-news.laohu8.com/highlight/detail?id=2585860434","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585860434?lang=en_us&edition=fundamental","pubTime":"2025-11-24 10:06","pubTimestamp":1763949972,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  secured membership to the medical countermeasures coalition, an international coalition of non-profit organizations, academic groups, and industry partners focusing on medical countermeasures, including vaccines, therapeutics, diagnostics, and related technologies, according to a Monday Australian bourse filing.The membership is expected to help advance the firm's Galidesivir antiviral molecule program, preceding pending regulatory, clinical, and stockpiling opportunities.Its shares jumped 14% in recent trading on Monday, earlier reaching an all-time peak.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","SKIS","ILA.AU"],"gpt_icon":0},{"id":"2584163296","title":"Island Pharmaceuticals Says FDA Confirms Animal Rule Pathway Appropriate for Approval of Marburg Virus Countermeasures, Shares Reach All-Time Peak","url":"https://stock-news.laohu8.com/highlight/detail?id=2584163296","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584163296?lang=en_us&edition=fundamental","pubTime":"2025-11-17 12:26","pubTimestamp":1763353565,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  said that the US Food and Drug Administration  confirmed, in response to questions posed in a Type C meeting request, that the animal rule pathway is appropriate for the approval of Marburg virus countermeasures, and that its antiviral drug candidate Galidesivir would qualify for a tropical disease priority review voucher on approval, according to a Monday Australian bourse filing.The animal rule allows drugs to be approved based on efficacy demonstrated in well-controlled animal studies when human trials are unethical or not feasible.The regulator provided guidance on the clinical program design. The company will incorporate all the US FDA guidance into Galidesivir's clinical development pathway.The firm plans to begin the Galidesivir clinical trial program to advance approval in the first quarter of 2026. It has the opportunity to submit questions to the US FDA by Dec. 2.Its shares jumped 24% in recent trading on Monday, earlier reaching an all-time high.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","SKIS","ILA.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ILA.AU\",params:#limit:6,delay:true,,,undefined,":[]}}